At the same time, the 14-week treatment of patients with RA with a TNF-alpha inhibitor (infliximab) showed a decrease in prothrombin (189 pmol/L (69–224 pmol/L) and D-dimer (752 ng/mL (507–1052 ng/mL)) [56]. This evidence concerns the gene F2 and rheumatoid arthritis.